Axogen Financial Statements From 2010 to 2026

AXGN Stock

USD 31.45 0.45 1.45%

Axogen's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Axogen's valuation are provided below:

Gross Profit

160.5 M

Profit Margin

(0.01)

Market Capitalization

1.4 B

Enterprise Value Revenue

6.8088

Revenue

214.7 M

We have found one hundred twenty available fundamental signals for Axogen Inc, which can be analyzed and compared to other ratios and to its rivals. Self-guided Investors are advised to validate Axogen's prevailing fundamentals against the trend between 2010 and 2026 to make sure the company can sustain itself down the road. As of the 5th of January 2026, Market Cap is likely to grow to about 276.8 M. Also, Enterprise Value is likely to grow to about 312.9 M

Axogen Total Revenue

226.21 Million

Check Axogen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Axogen's main balance sheet or income statement drivers, such as Depreciation And Amortization of 9.5 M, Interest Expense of 9.9 M or Total Revenue of 226.2 M, as well as many indicators such as Price To Sales Ratio of 3.33, Dividend Yield of 0.27 or PTB Ratio of 6.0. Axogen financial statements analysis is a perfect complement when working with Axogen Valuation or Volatility modules.

Build AI portfolio with Axogen Stock

Check out the analysis of Axogen Correlation against competitors.

Axogen Balance Sheet

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Total Assets

246 M

234.3 M

119.2 M

Slightly volatile

Short and Long Term Debt Total

82.9 M

79 M

39.5 M

Slightly volatile

Other Current Liabilities

24.9 M

23.7 M

10.1 M

Slightly volatile

Total Current Liabilities

37 M

35.2 M

16.2 M

Slightly volatile

Property Plant And Equipment Net

119.5 M

113.8 M

40.9 M

Slightly volatile

Cash

33.3 M

31.7 M

25 M

Slightly volatile

Non Current Assets Total

126.2 M

120.2 M

43.7 M

Slightly volatile

Cash And Short Term Investments

20.2 M

38.5 M

42.2 M

Slightly volatile

Net Receivables

29.1 M

27.7 M

13.4 M

Slightly volatile

Common Stock Shares Outstanding

53.4 M

50.9 M

31.2 M

Slightly volatile

Liabilities And Stockholders Equity

246 M

234.3 M

119.2 M

Slightly volatile

Non Current Liabilities Total

83.6 M

79.6 M

38 M

Slightly volatile

Inventory

40.1 M

38.2 M

13.9 M

Slightly volatile

Other Stockholder Equity

476.6 M

453.9 M

235.7 M

Slightly volatile

Total Liabilities

120.5 M

114.8 M

54.1 M

Slightly volatile

Property Plant And Equipment Gross

143.5 M

136.7 M

46.1 M

Slightly volatile

Total Current Assets

119.8 M

114.1 M

75.5 M

Slightly volatile

Short Term Debt

1.7 M

1.8 M

4.5 M

Pretty Stable

Intangible Assets

5.3 M

5 M

2.2 M

Slightly volatile

Other Current Assets

10.2 M

9.7 M

4.9 M

Slightly volatile

Accounts Payable

9.7 M

9.2 M

5.2 M

Slightly volatile

Common Stock Total Equity

512 K

487.6 K

322.5 K

Slightly volatile

Common Stock

532.5 K

507.1 K

326.3 K

Slightly volatile

Other Liabilities

2.6 K

2.7 K

208.3 K

Slightly volatile

Property Plant Equipment

113.1 M

107.7 M

38.3 M

Slightly volatile

Long Term Debt

34.9 M

54.6 M

31.6 M

Slightly volatile

Long Term Debt Total

79.8 M

76 M

37.7 M

Slightly volatile

Capital Surpluse

210.4 M

414.2 M

217.3 M

Slightly volatile

Short and Long Term Debt

737.9 K

776.7 K

9.8 M

Slightly volatile

Net Invested Capital

149.3 M

174.1 M

103.4 M

Slightly volatile

Net Working Capital

72 M

61.7 M

67.5 M

Slightly volatile

Capital Stock

456.3 K

507.1 K

410.6 K

Slightly volatile

Non Current Liabilities Other

44.8 K

84.6 K

90.1 K

Slightly volatile

Capital Lease Obligations

24 M

24.4 M

21.5 M

Slightly volatile

Axogen Income Statement

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Depreciation And Amortization

9.5 M

9 M

3 M

Slightly volatile

Interest Expense

9.9 M

9.4 M

3.9 M

Slightly volatile

Total Revenue

226.2 M

215.4 M

90 M

Slightly volatile

Gross Profit

171.4 M

163.3 M

70.7 M

Slightly volatile

Other Operating Expenses

230.2 M

219.2 M

103.1 M

Slightly volatile

Cost Of Revenue

54.8 M

52.2 M

19.3 M

Slightly volatile

Total Operating Expenses

175.4 M

167.1 M

83.7 M

Slightly volatile

Selling General Administrative

47.1 M

44.9 M

22.4 M

Slightly volatile

Research Development

33.5 M

31.9 M

14.1 M

Slightly volatile

Selling And Marketing Expenses

48.7 M

90.2 M

44.9 M

Slightly volatile

Interest Income

2.5 M

2.1 M

3.1 M

Slightly volatile

Reconciled Depreciation

9.5 M

9 M

3.1 M

Slightly volatile

Axogen Cash Flow Statement

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Begin Period Cash Flow

44.7 M

42.6 M

26.9 M

Slightly volatile

Depreciation

9.5 M

9 M

3 M

Slightly volatile

Capital Expenditures

3.6 M

5.2 M

6.9 M

Slightly volatile

End Period Cash Flow

40.5 M

38.6 M

28.3 M

Slightly volatile

Stock Based Compensation

19.2 M

18.3 M

7.6 M

Slightly volatile

Change To Netincome

20.2 M

19.2 M

9.3 M

Slightly volatile

Financial Ratios

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Price To Sales Ratio

3.33

3.5

5.0166

Very volatile

Dividend Yield

0.27

0.26

0.2671

Slightly volatile

Days Sales Outstanding

51.31

54.01

60.7686

Slightly volatile

Average Payables

3.2 M

3.1 M

3 M

Slightly volatile

Stock Based Compensation To Revenue

0.0928

0.0976

0.4389

Slightly volatile

Capex To Depreciation

0.49

0.52

4.9725

Very volatile

EV To Sales

3.52

3.7

5.1529

Very volatile

Inventory Turnover

2.84

1.57

1.4722

Very volatile

Days Of Inventory On Hand

175

240

293

Slightly volatile

Payables Turnover

6.19

6.51

3.1374

Slightly volatile

Sales General And Administrative To Revenue

0.36

0.24

0.3518

Slightly volatile

Average Inventory

3.1 M

2.9 M

3 M

Slightly volatile

Research And Ddevelopement To Revenue

0.1

0.13

0.1513

Very volatile

Capex To Revenue

0.0206

0.0217

0.1264

Pretty Stable

Cash Per Share

0.67

0.68

1.3575

Very volatile

Days Payables Outstanding

85.83

57.99

152

Slightly volatile

Intangibles To Total Assets

0.0527

0.0315

0.0253

Pretty Stable

Current Ratio

2.77

2.92

6.022

Slightly volatile

Receivables Turnover

6.64

6.99

6.1396

Slightly volatile

Capex Per Share

0.0874

0.092

0.3475

Pretty Stable

Average Receivables

9 M

8.6 M

6.7 M

Slightly volatile

Revenue Per Share

4.0

3.81

2.3284

Slightly volatile

Interest Debt Per Share

1.54

2.0

1.3605

Pretty Stable

Debt To Assets

0.32

0.3

0.4638

Slightly volatile

Graham Number

13.48

12.84

13.4603

Slightly volatile

Operating Cycle

244

283

354

Slightly volatile

Days Of Payables Outstanding

85.83

57.99

152

Slightly volatile

Ebt Per Ebit

2.86

2.73

1.5447

Slightly volatile

Long Term Debt To Capitalization

0.27

0.28

0.4846

Slightly volatile

Total Debt To Capitalization

0.58

0.46

0.5493

Slightly volatile

Quick Ratio

1.84

1.94

5.0749

Slightly volatile

Net Income Per E B T

1.21

1.15

1.0195

Slightly volatile

Cash Ratio

0.77

0.81

3.0214

Slightly volatile

Cash Conversion Cycle

174

225

Pretty Stable

Days Of Inventory Outstanding

175

240

293

Slightly volatile

Days Of Sales Outstanding

51.31

54.01

60.7686

Slightly volatile

Free Cash Flow Operating Cash Flow Ratio

0.0021

0.0022

1.7035

Pretty Stable

Fixed Asset Turnover

1.62

1.7

15.4667

Slightly volatile

Debt Ratio

0.32

0.3

0.4638

Slightly volatile

Price Sales Ratio

3.33

3.5

5.0166

Very volatile

Asset Turnover

0.94

1.06

0.7266

Slightly volatile

Gross Profit Margin

0.46

0.68

0.7245

Pretty Stable

Axogen Valuation Data

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Market Cap

276.8 M

263.6 M

359.7 M

Pretty Stable

Enterprise Value

312.9 M

298 M

379.7 M

Pretty Stable

Axogen Fundamental Market Drivers

	Forward Price Earnings	77.5194
	Cash And Short Term Investments	33.5 M

Axogen Upcoming Events

	12th of March 2024 Upcoming Quarterly Report	View
	14th of May 2024 Next Financial Report	View
	31st of December 2023 Next Fiscal Quarter End	View
	12th of March 2024 Next Fiscal Year End	View
	30th of September 2023 Last Quarter Report	View
	31st of December 2022 Last Financial Announcement	View

About Axogen Financial Statements

Axogen investors utilize fundamental indicators, such as revenue or net income, to predict how Axogen Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.

	Last Reported	Projected for Next Year
Current Deferred Revenue	12.6 K	12 K
Total Revenue	215.4 M	226.2 M
Cost Of Revenue	52.2 M	54.8 M
Stock Based Compensation To Revenue	0.10	0.09
Sales General And Administrative To Revenue	0.24	0.36
Research And Ddevelopement To Revenue	0.13	0.10
Capex To Revenue	0.02	0.02
Revenue Per Share	3.81	4.00
Ebit Per Revenue	(0.02)	(0.02)

Pair Trading with Axogen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Axogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axogen will appreciate offsetting losses from the drop in the long position's value.

Moving together with Axogen Stock

0.84

DHR

Danaher

Pair Corr

Moving against Axogen Stock

0.9	OM	Outset Medical	Pair Corr
0.76	HPQ	HP Inc	Pair Corr
0.75	PG	Procter Gamble	Pair Corr
0.73	GOOD	Gladstone Commercial	Pair Corr
0.63	T	ATT Inc	Pair Corr

The ability to find closely correlated positions to Axogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Axogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Axogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Axogen Inc to buy it.

The correlation of Axogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Axogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Axogen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Axogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Axogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Axogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Axogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Axogen Inc Stock:

How To Invest In Axogen

Details

Is Axogen Stock a good investment?

Details

What is Axogen's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of Axogen Correlation against competitors.

You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axogen. If investors know Axogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.05)

Revenue Per Share

4.67

Quarterly Revenue Growth

0.235

Return On Assets

0.0121

Return On Equity

(0.02)

The market value of Axogen Inc is measured differently than its book value, which is the value of Axogen that is recorded on the company's balance sheet. Investors also form their own opinion of Axogen's value that differs from its market value or its book value, called intrinsic value, which is Axogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axogen's market value can be influenced by many factors that don't directly affect Axogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Axogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Axogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Axogen Financial Statements From 2010 to 2026

Axogen Total Revenue

226.21 Million

Axogen Balance Sheet

Axogen Income Statement

Axogen Cash Flow Statement

Financial Ratios

Axogen Valuation Data

Axogen Fundamental Market Drivers

Axogen Upcoming Events

About Axogen Financial Statements

Pair Trading with Axogen

Moving together with Axogen Stock

Moving against Axogen Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY